University of Louisville
Shirwan, Michael and Joan Hamilton Endowed Chair in Autoimmune Disease, Professor of Microbiology and Immunology and the Director of the Molecular Immunomodulation Program at the Institute for Cellular Therapeutics. He conducted his graduate studies at the University of California in Santa Barbara, CA and postdoctoral studies at California Institute of Technology in Pasadena CA. He joined the University of Louisville in 1998 after holding academic appointments at various institutions in the United States. Shirwans research focuses on the modulation of immune system for the treatment of immune based diseases with particular focus on type 1 diabetes transplantation and development of vaccines against infections and cancer. Shirwan is widely published lectured at various National/International conferences served on various federal and nonprofit funding agencies and is on the Editorial Board of nine scientific journals He is a member of several National and International societies and the recipient of various awards.
Immunomodulation using proprietary novel recombinant proteins under clinically applicable protocols for therapeutic purposes with major focus on: Type 1 diabetes,Graft rejection,Bone marrow transplantation,Vaccines (cancer and infectious diseases)